Medicare Reform: The Pharmacy Perspective John M. Coster, Ph.D., R.Ph. The National Medicare Prescription Drug Congress February 26, 2004.

Slides:



Advertisements
Similar presentations
1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute Families USA Health Action 2005.
Advertisements

Pharmacy Services Agreements Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 5/08/06.
Pharmacy Benefit Managers (PBMs)
Adam J. Falk, Esq. FELDESMAN TUCKER LEIFER FIDELL LLP Legal issues for Medicaid Plans Under Part D in Serving Dual Eligibles MEDICAID HEALTH PLANS OF AMERICA.
Challenges of Serving Low-income Medicare Beneficiaries: Impact of Cost Sharing Cindy Parks Thomas Brandeis University Schneider Institute for Health Policy.
2006 Retiree MIP Overview October 2006 Rajiv Nundy & Kent Humphries HR Compensation Management.
Supplementing PACE through Medicare Part D
Ideas for People Losing Illinois Cares Rx Benefits July 2011.
MEDICARE: PAST, PRESENT AND F UTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.
Deciphering Medicare Part D Susan Miller, Patient Education Douglas A. Magenheim, MD, MBA, FACP.
Meeting the Medication Needs of Iowans: the IowaCare Pilot Pharmaceutical Program and UIHC Medication Assistance Center Lisa Mascardo, PharmD Assistant.
Long Term Care: Medicare Prescription Drug Coverage in Institutions and Our Communities Larry Kocot Vanessa Duran.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health? Get Educated, Get Enrolled An.
Medicare and the New Prescription Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser.
TAYLOR MELANSON Providing Prescription Drug Coverage to the Elderly: America’s Experiment with Medicare Part D By Mark Duggan, Patrick Healy, and Fiona.
Medicare Part D Overview of Options, Creditable Coverage, Required Notices, COB and Health Care Reform.
Strategic Implications of the New Medicare Prescription Drug Legislation G. Lawrence Atkins, PhD Schering-Plough Corporation The Pharma, Biotech and Device.
PBM Transactions Medicaid DRA Rule –Proposed Rule AMP includes “Discounts, rebates or other price concessions to PBMs associated with sales for drugs provided.
Joint Informational Hearing The Federal Medicare Prescription Drug Act: State Readiness, Implementation, and Consumer Issues Bonnie Burns, Training and.
Agenda Trends in the Senior Market Part D Benefits & Guidelines
MEDICARE PRESCRIPTION DRUG BENEFIT Presented by Juliette Cubanski, Ph.D. Principal Policy Analyst Medicare Policy Project The Henry J. Kaiser Family Foundation.
1 State Perspectives on Medicare Part D: Lessons from Pharmacy Plus Programs Cindy Parks Thomas Donald Shepard Christine E. Bishop Daniel M. Gilden Brandeis.
Copay Structure Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?
Jeffrey Levi, Ph.D. American Public Health Association Annual Meeting November 8, 2004 Options for enhancing quality and equity in the CARE Act: If not.
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Roy Trudel, CMSO National Eligibility Workers Association 07/12/05.
MEDICARE PART D Are We Ready? Are We Ready?. Medicare Part D Overview Medicare Part A and B covers individuals Age 65 and older Age 65 and older Those.
(c) 2012 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.
Medicare and Patient Assistance Sean M. Dougherty Senior Director Medicare Strategy & Patient Assistance Programs Government, Public Policy And Managed.
Agribusiness Library LESSON: HEALTH INSURANCE. Objectives 1. Determine the function of health insurance, and define common health insurance terms. 2.
 The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27,
The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.
1 Variation in Medicare Part D Prescription Drug Plan Benefits, 2006 Leslie M. Greenwald, Ph.D. Principal Scientist RTI, International.
0 Beneficiary Choices in Medicare Part D and Plan Features in 2006 Supported by PhRMA September 13, 2006.
Focus on the Drug Payment Methods Landscape Academy of Managed Care Pharmacy April 17, 2009.
Avalere Health LLC | The intersection of business strategy and public policy The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries.
FINANCIAL ISSUES CHAPTER 14. CHAPTER OUTLINE Financial Issues Third-Party Programs – private health insurance – managed care programs – public health.
Slide 1 Drug Pricing Considerations Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ___________ Copyright 2005 Arnold & Porter July.
1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute National Academy of Social Insurance.
Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.
Pharma Audioconference: PBM Regulation, Investigation, Prosecution and Compliance February 10, 2004 Stephanie W. Kanwit, Esq. Special Counsel Pharmaceutical.
Retiree Health Benefits Program Medicare Part D and Your State Benefits Your Benefits Choices.
Avalere Health LLC | The intersection of business strategy and public policy The Medicare Modernization Act: The Impact on States and Low-Income Beneficiaries.
Ramón Castellblanch, PhD Senior Action Network California Alliance of Retired Americans Joint Informational Hearing Medicare Prescription Drug Coverage.
1 Cost Sharing for Low-Income Beneficiaries and Supplementing Part D Examples from Pharmacy Plus Medicaid Demonstration Programs Summit for State Health.
1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.
1 State Options for Supplementing Medicare Part D Drug Coverage Invitational Summit on Medicare Part D Implementation Issues Jack Hoadley Georgetown University.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
Managed Care Pharmacy Financials January 15, 2015.
Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Finding the path to a healthier plan choice Aetna Medicare.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
Technology, Information Systems and Reporting in Pharmacy Benefit Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February.
Pharmacy Benefit Management (PBM) 101
MEDICATION USE IN RURAL AMERICA ASSOCIATION UPDATES National Community Pharmacists Association Tina Schlecht, PharmD, MBA Director, Pharmacy Affairs.
The Pharmacy Technician 4E
Medicare and Medicaid Week 3.
National Medicare Prescription Drug Congress
2018 Medicare Prescription Drug Benefit
Director, Pennsylvania PACE Program National Medicare Congress
Lauren Geyer Barnes Avalere Health LLC
Healthcare Reform and Medicare Part D
Third National Medicare Congress
Medicare Part D Benefit: A Primer
Medicare Rx Legislation: Implications for PBMs
Will PBMs Participate in the New Medicare Prescription Drug Program
Jan Berger, M.D., M.J. Senior Vice President Chief Medical Officer
Medicare Rx Drug Benefit
Presented by Tricia Neuman, Sc.D.
Medicare Reform: Implications for Pharmaceutical Manufacturers
Medicare Part D Implementation Issues: Key Decisions for States
Presentation transcript:

Medicare Reform: The Pharmacy Perspective John M. Coster, Ph.D., R.Ph. The National Medicare Prescription Drug Congress February 26, 2004

Community Pharmacy Issues » PBA Coalition Pharmacy Access Standards Retail Pharmacy Equity with Mail Order Transparency and Accountability by PBMs No Transfer of Risk from PBMs to Pharmacies Conversion of Medicaid to Medicare Modifications of State Rx Assistance Program Preemption state Rx benefit laws Medication therapy management

Pharmacies critical to managing… » …and administering the card and coverage programs in general » …and especially the expectations of seniors about what the benefit is and is not » …we will be on the front line answering questions about Card programs – new and existing Coverage programs – actuarially equivalence, formulary, donut holes, etc… Medicaid and SPAP conversions Formularies Coordinating Benefits between plans and payors

Medicare - Discount Card Coordinating endorsed and non endorsed programs Passing along lower of “U+C” or negotiated rate Working with Medicaid programs and SPAPs that want to wrap or pay copays Explaining the pricing website to seniors and why drugs and prices have changed TriCare pharmacy access standards  90 percent urban – within 2 miles of pharmacy  90 percent suburban – within 5 miles of pharmacy  70 percent rural – within 15 miles of pharmacy

Management and Administrative Issues » Implementing Formularies and Tiered copays Include “drugs” within each therapeutic class Appeals process to obtain access to MD prescribed Rx Coordinating benefits with other plans has to be done in an on line real time manner Pharmacists already spend 25% of time on third party administrative issues

Access to Pharmacies » Any pharmacy “willing” to accept terms and conditions may participate in network » BUT – PDP plans can reduce coinsurance or copayments for “in network” pharmacies below that otherwise required » “In network” pharmacies (other than mail order) have to meet TriCare access standards. » LTC Access Standards: “such rules may include standards with respect to access for enrollees who are residing in long term care facilities…”

TriCare Access Standards » Urban: a pharmacy within 2 miles of 90 percent of the beneficiaries » Suburban: a pharmacy within 5 miles of 90 percent of the beneficiaries » Rural: a pharmacy within 15 miles of 70 percent of the beneficiaries Average vs. actual Definition of pharmacy How distances are measured

Mail Order » Plans can use differential copays to encourage mail order – lets look at report language and Congressional history! » Plans have to “permit enrollees to receive benefits (which may include a 90-day supply of drugs or biologicals) through a pharmacy (other than a mail order pharmacy), with any differential in charge paid by such enrollees

Insurance Risk » “The terms and conditions under subparagraph (A) may not require participating pharmacies to accept insurance risk as a condition of participation” » “Insurance risk is defined as…risk of the type commonly assumed only by insurers licensed by a State and does not include payment variations designed to reflect performance- based measures of activities within the control of the pharmacy, such as formulary compliance and generic drug substitution”

Negotiated Prices » Sponsor has to provide enrollees with access to “negotiated prices”…regardless of the fact that no benefits may be payable under the coverage with respect to such drugs because of application of a deductible or other cost sharing or an initial coverage limit…” » “…negotiated prices shall take into account negotiated price concessions, such as discounts, direct or indirect subsidies, rebates, and direct or indirect remunerations, and include any dispensing fees for such drugs.”

Transparency and Disclosures » PDP or MA-PD sponsor shall disclose…aggregated negotiated price concessions…made available to the sponsor or organization by a manufacturer which are passed through in the form of lower subsidies, lower monthly beneficiary prescription drug premiums, and lower prices through pharmacies and other dispensers.

Medicare Rx Impact on Medicaid » Medicare becomes primary payor for Rx drugs for dual eligibles » No Federal matching funds available on January 1, 2006 for states for Medicare covered drugs or copays » Medicaid can provide these drugs, but at their own cost » Secretary to establish process to transfer duals to Medicare » Pharmacy has option to waive Rx copays » Federal government “claws back” state savings resulting from shift of dual eligibles, phasing from 90 percent in 2006 to 75 percent in 2014

Waiver of Copays » Pharmacies can waive copays for dual eligibles if the waiver is not offered as part of any advertisement or solicitation » Pharmacies can waive copays for non dual eligibles if: the waiver is not offered as part of any advertisement or solicitation pharmacy does not routinely waive copay and; Pharmacy waives copay after determining in good faith that individual is in financial need or Fails to collect copay after making reasonable efforts

FTC Mail Order Study » Conflict of interest study Federal Trade Commission directed to study differences in payment for pharmacy services provided to enrollees of group health plans that use PBMs Includes study on differences in costs for drugs dispensed by PBM-owned mail order pharmacies, independent mail order pharmacies, and community pharmacies Report to analyze effect on competition and enrollee pricing and potential impact on Medicare spending of use of PBM-owned mail order pharmacies Specifically directed to review use of generic drugs, repackaged drugs, and drug switching

Electronic Prescribing Electronic prescribing Voluntary program to electronically transmit prescription information between physicians and pharmacies –Information to include medical history, drug interactions, availability of lower cost alternatives Secretary to conduct pilot program in 2006 and publish final standards by April 1, 2008, effective no later than one year later Pharmacies participating will need to comply with standards Physicians supposed to provide information to patients on choice of pharmacy

Part B DME Changes » DME payment freeze » Lower rates for certain items such as diabetic test strips and lancets in 2005 » Competitive bidding begins in 2007 in 10 largest MSAs’; expanded to 90 MSAs in Covered items include most DME classes Retail pharmacies eligible to bid, but participation not guaranteed Established rates can apply in non-competitive bidding areas

Part B AWP Changes » For 2004, most Part B drugs paid at AWP-15 plus supplier fee (for oral cancer, immunosuppressive and oral anti-emetic drugs) » CMS did not establish supplier fee » For 2005, payment at Average Sales Price (ASP) plus 6% or WAC, whichever lower, plus supplier fee » Secretary also to establish a competitive bidding program for Part B drugs which may limit their distribution to mail order and/or specialty supplier.

Medicare Reform: The Pharmacist Perspective Susan C. Winckler, RPh, Esq The National Medicare Prescription Drug Congress February 26, 2004

Primary Roles… » Benefit ‘counselor’ and educator For discount card, transitional assistance and benefit » Benefit Administrator For discount card, transitional assistance and benefit » Medication Therapy Management Provider For discount card? For benefit

Benefit ‘counselor’ and educator » Discount Cards Provide guidance on choosing endorsed discount card » Transitional Assistance Provide guidance on availability of assistance » Benefit Provide guidance on choosing among competing plans Repeat with renewals

Benefit ‘counselor’ and educator » What we need to be successful Discount cards Information! Prices (including generics covered under the card) Transitional assistance Information! Benefit Information! Formularies, benefit parameters

Benefit Administrator » Discount Cards Navigate various cards Continue to provide information on less- expensive alternatives Provide price of appropriate generics under card Explain formularies, plan limits, scope of discounts Administer transitional assistance funds

Benefit Administrator » 2006 Benefit Introduce many beneficiaries to third-party payor dynamics Refill limits Formularies and appeals processes Medicare dynamics Co-insurance ‘Donut hole’

Benefit Administrator » What we need to be successful Discount cards Information! Prices (including generics covered under the card) Transitional assistance Information! Real-time access to balance Benefit Information! Formularies, potential changes to formularies, balance approaching coverage gap

Medication Therapy Management Provider » Best provided in direct patient care relationship » Making the best use of medications Medication reviews Beneficiary education about therapy Compliance interventions Packaging CLIA-waived testing? Ongoing consultation and follow-up

Medication Therapy Management Provider » What we need to be successful Opportunity to participate No arbitrary restrictions Adequate scope of services Sufficient compensation Separate from dispensing to avoid perverse incentives

Questions?